Form 4: HealthLynked Corp CEO Acquires Warrants as Consideration for Convertible Note Extension
SEC Form 4 Filing
Michael Dent, CEO of HealthLynked Corp, acquired warrants to purchase 393,750 shares of common stock as partial consideration for extending a convertible promissory note.
Summary
- Michael Dent, the CEO of HealthLynked Corp, filed a Form 4 detailing a transaction involving derivative securities.
- On June 27, 2024, Dent's trust received warrants to purchase 393,750 shares of HealthLynked's common stock at an exercise price of $0.081 per share.
- These warrants were granted as partial consideration for a 6-month extension of a previously issued convertible promissory note.
- The warrants are exercisable immediately and expire on June 26, 2034.
- The warrants are held indirectly by the Mary S. Dent Gifting Trust, with Michael Dent as the trustee.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports a transaction.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The warrant issuance could potentially dilute existing shareholders if the warrants are exercised.
Key Dates
| Date | Description |
|---|---|
| January 31, 2006 | Date of the Mary S. Dent Gifting Trust |
| June 27, 2024 | Date of warrant transaction and exercisable date |
| June 26, 2034 | Expiration date of the warrants |
| June 28, 2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.